Education
About Us
Working with TipRanks
Follow Us
Lifeward (LFWD)
NASDAQ:LFWD
LFWD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.25 - $6.00
Previous CloseN/A
Volume483.00K
Average Volume (3M)4.73M
Market Cap
$19.45M
Enterprise Value$18.88M
Total Cash (Recent Filing)$6.75M
Total Debt (Recent Filing)$880.00K
Price to Earnings (P/E)―
Beta1.79
Next Earnings
May 08, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.32
Shares Outstanding10,630,281
10 Day Avg. Volume11,000,802
30 Day Avg. Volume4,732,943
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.71
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market Cap0.97
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.30
Enterprise Value/Ebitda-1.14
Forecast
1Y Price Target
$9.00Price Target Upside391.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceLifeward's Q4 results showed a gross margin of 45.4%, ahead of the 41.9% expectation.
Operational StrategyThe company initiated the closing of two U.S. facilities with the full integration of the AlterG business segment, for a projected savings of approximately $3M.
Partnerships And Market ExpansionRecent developments help diversify Lifeward's business through an exclusive partnership with CorLife and an expanded distribution agreement with MYOLYN.
Bears Say
Financial ResultsThe company reported a net loss of $1.73 per share, compared to consensus estimated net loss of $0.31 per share.
Reimbursement ChallengesThe company continues to experience longer than expected time to receive CMS reimbursement.
Revenue ExpectationsQ3 turned out to not be the record quarter the company anticipated on the Q2 call as revenue of $6.1M significantly missed our $8.5M expectation.
---
Ownership Overview
11.18% Insiders
0.20% Mutual Funds
0.11% Other Institutional Investors
88.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
LFWD FAQ
What was Lifeward’s price range in the past 12 months?
Lifeward lowest stock price was $1.25 and its highest was $6.00 in the past 12 months.
What is Lifeward’s market cap?
Lifeward’s market cap is $19.45M.
When is Lifeward’s upcoming earnings report date?
Lifeward’s upcoming earnings report date is May 08, 2025 which is in 41 days.
How were Lifeward’s earnings last quarter?
Lifeward released its earnings results on Mar 07, 2025. The company reported -$1.73 earnings per share for the quarter, missing the consensus estimate of -$0.543 by -$1.187.
Is Lifeward overvalued?
According to Wall Street analysts Lifeward’s price is currently Undervalued.
Does Lifeward pay dividends?
Lifeward does not currently pay dividends.
What is Lifeward’s EPS estimate?
Lifeward’s EPS estimate is -0.33.
How many shares outstanding does Lifeward have?
Lifeward has 10,630,281 shares outstanding.
What happened to Lifeward’s price movement after its last earnings report?
Lifeward reported an EPS of -$1.73 in its last earnings report, missing expectations of -$0.543. Following the earnings report the stock price went up 3.165%.
Which hedge fund is a major shareholder of Lifeward?
Currently, no hedge funds are holding shares in LFWD
---
Company Description
Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
---
LFWD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and strategic partnerships, coupled with operational improvements. However, challenges such as ReWalk sales not meeting expectations, a decrease in gross margin, and financial health concerns tempered the positive aspects.Read More>---
LFWD Stock 12 Month Forecast
Average Price Target
$9.00
▲(391.80% Upside)
Technical Analysis
Best Analysts Covering LFWD
1 Year
1 Year Success Rate
3/16 ratings generated profit
1 Year Average Return
-23.97%
reiterated a buy rating 17 days ago
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 18.75% of your transactions generating a profit, with an average return of -23.97% per trade.
---